Boston Scientific Corporation BSX today announced it has received CE Mark for its OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System, the Company's third-generation coronary stenting technology.
The Company will immediately begin marketing the OMEGA Stent System in the European Union and other CE Mark countries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
